Company · CIK 0001434316 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
FATE THERAPEUTICS INC · FATE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 SForm 4 → | Aug 5, 4:03 pm EDT | Cindy TahlSee Remarks | 38,800 | $2.46 | $95,405 | 589,355 | −6.18% | |
| Aug 4, 2026 SForm 4 → | Aug 5, 4:01 pm EDT | Bahram ValamehrPresident and CEO, Director | 43,947 | $2.46 | $108,101 | 591,815 | −6.91% | |
| Mar 1, 2019 SForm 4 → | Mar 5, 9:00 am EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | $16.15 | $403,698 | 90,418 | −21.7% | plan? |
| Mar 1, 2019 MForm 4 → | Mar 5, 9:00 am EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | $2.90 | $72,500 | 115,418 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 4:01 pm EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | $16.07 | $401,820 | 90,418 | −21.7% | plan? |
| Feb 25, 2019 MForm 4 → | Feb 27, 4:01 pm EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | $2.90 | $72,500 | 115,418 | — | plan? |
| Jan 30, 2019 SForm 4 → | Feb 1, 5:02 pm EST | Amir NashatDirector | 53,017 | $14.16 | $750,959 | 1,473,186 | −3.47% | plan? |
| Jan 29, 2019 SForm 4 → | Jan 31, 6:00 pm EST | Amir NashatDirector | 97,500 | $14.16 | $1,380,795 | 1,526,203 | −6.00% | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 4:10 pm EST | Amir NashatDirector | 70,000 | $13.78 | $964,768 | 1,623,703 | −4.13% | plan? |
| Jan 25, 2019 SForm 4 → | Jan 29, 4:31 pm EST | Amir NashatDirector | 90,000 | $14.14 | $1,272,753 | 1,693,703 | −5.05% | plan? |
| Jan 18, 2019 SForm 4 → | Jan 23, 4:32 pm EST | Amir NashatDirector | 39,483 | $16.28 | $642,834 | 1,783,703 | −2.17% | plan? |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:05 pm EST | J Scott WolchkoPresident and CEO, Director | 250,000 | — | — | 374,881 | — | plan? |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:04 pm EST | Bahram ValamehrChief Development Officer | 45,000 | — | — | 72,958 | — | plan? |
| Jan 7, 2019 SForm 4 → | Jan 9, 4:03 pm EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | $16.00 | $400,000 | 45,418 | −35.5% | plan? |
| Jan 7, 2019 AMForm 4 → | Jan 9, 4:03 pm EST | Cindy TahlGeneral Counsel and Secretary | 70,000 | $2.27 | $56,673 | 90,418 | — | plan? |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:01 pm EST | Daniel D ShoemakerChief Scientific Officer | 45,000 | — | — | 135,591 | — | plan? |
| Dec 20, 2018 SForm 4 → | Dec 26, 4:13 pm EST | Amir NashatDirector | 33,474 | $12.25 | $410,160 | 1,823,186 | −1.80% | plan? late |
| Dec 19, 2018 SForm 4 → | Dec 21, 4:12 pm EST | Amir NashatDirector | 91,210 | $13.40 | $1,222,592 | 1,856,660 | −4.68% | plan? |
| Dec 13, 2018 SForm 4 → | Dec 17, 4:25 pm EST | Amir NashatDirector | 17,788 | $16.67 | $296,563 | 1,947,870 | −0.90% | plan? |
| Dec 12, 2018 SForm 4 → | Dec 14, 4:33 pm EST | Amir NashatDirector | 425,000 | $16.78 | $7,132,690 | 1,965,658 | −17.8% | plan? |
| Dec 11, 2018 SForm 4 → | Dec 13, 5:14 pm EST | Amir NashatDirector | 82,528 | $16.71 | $1,379,183 | 2,390,658 | −3.34% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 27, 4:23 pm EDT | Redmile Group, LLC +1Director, 10% Owner | 3,703,704 | $13.50 | $50,000,004 | 10,359,666 | +55.6% | plan? |
| May 15, 2018 MForm 4 → | May 16, 5:28 pm EDT | Stewart AbbotChief Development Officer | 21,054 | $6.62 | $139,411 | 64,917 | — | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 4:05 pm EDT | J Scott WolchkoPresident and CEO, Director | 17,168 | $3.88 | $66,600 | 124,881 | −12.1% | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 4:04 pm EDT | Cindy TahlGeneral Counsel and Secretary | 8,091 | $3.85 | $31,124 | 45,418 | −15.1% | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 4:04 pm EDT | Daniel D ShoemakerChief Scientific Officer | 13,225 | $3.87 | $51,203 | 90,591 | −12.7% | plan? |
| Nov 23, 2016 PForm 4 → | Nov 28, 3:46 pm EST | Chris StorgardChief Medical Officer | 37,593 | $2.66 | $99,997 | 37,593 | — | plan? |
| Nov 23, 2016 PForm 4 → | Nov 28, 3:44 pm EST | William H RastetterDirector | 375,939 | $2.66 | $999,998 | 459,272 | +451% | plan? |
| Nov 23, 2016 PForm 4 → | Nov 28, 3:42 pm EST | Timothy P CoughlinDirector | 56,390 | $2.66 | $149,997 | 56,390 | — | plan? |
| Aug 23, 2016 MForm 4 → | Aug 24, 6:55 pm EDT | J Scott WolchkoPresident and CEO, Director | 2,570 | $1.37 | $3,521 | 142,049 | — | plan? |
| May 16, 2016 AForm 4 → | May 18, 12:19 pm EDT | Chris StorgardChief Medical Officer | 9,090 | — | — | 9,090 | — | plan? |
| Jan 18, 2016 MForm 4 → | Jan 20, 2:32 pm EST | J Scott WolchkoPresident and CEO, Director | 7,500 | $1.50 | $11,238 | 139,479 | — | plan? |
| Jan 12, 2016 AForm 4 → | Jan 14, 4:35 pm EST | J Scott WolchkoPresident and CEO, Director | 10,956 | — | — | 131,979 | — | plan? |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:33 pm EST | Cindy TahlGeneral Counsel and Secretary | 6,633 | — | — | 53,509 | — | plan? |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:32 pm EST | Daniel D ShoemakerChief Scientific Officer | 9,388 | — | — | 103,816 | — | plan? |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:30 pm EST | Stewart AbbotChief Development Officer | 3,863 | — | — | 43,863 | — | plan? |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:35 pm EDT | Daniel D ShoemakerChief Scientific Officer | 66,000 | — | — | 94,428 | — | plan? |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:34 pm EDT | J Scott WolchkoCFO & Chief Operating Officer | 86,250 | — | — | 121,023 | — | plan? |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:33 pm EDT | Stewart AbbotChief Development Officer | 40,000 | — | — | 40,000 | — | plan? |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:32 pm EDT | Cindy TahlGeneral Counsel and Secretary | 40,000 | — | — | 46,876 | — | plan? |
| Apr 13, 2015 MForm 4 → | Apr 14, 4:22 pm EDT | J Scott WolchkoSee Remarks | 8,000 | $1.47 | $11,723 | 34,773 | — | plan? |
| Apr 13, 2015 MForm 4 → | Apr 14, 3:52 pm EDT | Christian WeyerSee Remarks, Director | 25,000 | $1.37 | $34,250 | 30,429 | — | plan? |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:42 pm EST | Peter D FlynnSee remarks | 2,466 | — | — | 6,505 | — | plan? |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:35 pm EST | Daniel D ShoemakerChief Research Officer | 2,466 | — | — | 28,428 | — | plan? |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:30 pm EST | Pratik S MultaniChief Medical Officer | 3,024 | — | — | 3,024 | — | plan? |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:22 pm EST | J Scott WolchkoSee remarks | 2,885 | — | — | 26,773 | — | plan? |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:15 pm EST | Christian WeyerSee remarks, Director | 5,429 | — | — | 5,429 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 AForm 4 → | Jun 15, 5:16 pm EDT | Redmile Group, LLC +1Director, 10% Owner | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:15 pm EDT | Michael Stewart LeeDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:10 pm EDT | Yuan XuDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:09 pm EDT | Karin JoossDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:08 pm EDT | Robert S EpsteinDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:08 pm EDT | Shefali AgarwalDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:07 pm EDT | Matt AbernethyDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:06 pm EDT | William H RastetterDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:05 pm EDT | Laura HamillDirector | 175,800 | — | — | 175,800 | — | |
| Mar 1, 2019 MForm 4 → | Mar 5, 9:00 am EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | — | — | 73,149 | — | |
| Feb 25, 2019 MForm 4 → | Feb 27, 4:01 pm EST | Cindy TahlGeneral Counsel and Secretary | 25,000 | — | — | 98,149 | — | |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:05 pm EST | J Scott WolchkoPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:04 pm EST | Bahram ValamehrChief Development Officer | 135,000 | — | — | 135,000 | — | |
| Jan 7, 2019 AMForm 4 → | Jan 9, 4:03 pm EST | Cindy TahlGeneral Counsel and Secretary | 160,000 | — | — | 135,000 | — | |
| Jan 7, 2019 AForm 4 → | Jan 9, 4:01 pm EST | Daniel D ShoemakerChief Scientific Officer | 135,000 | — | — | 135,000 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 6:11 am EDT | Redmile Group, LLC +1Director, 10% Owner | 24,000 | — | — | 24,000 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 6:09 am EDT | Michael Stewart LeeDirector | 24,000 | — | — | 24,000 | — | |
| Jul 18, 2018 AForm 4/A → | Aug 3, 4:09 pm EDT | J Scott WolchkoPresident and CEO, Director | 152,000 | — | — | 152,000 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 4:04 pm EDT | J Scott WolchkoPresident and CEO, Director | 450,000 | — | — | 450,000 | — | amended |
| May 15, 2018 MForm 4 → | May 16, 5:28 pm EDT | Stewart AbbotChief Development Officer | 21,054 | — | — | 51,862 | — | |
| May 2, 2018 AForm 4 → | May 4, 4:20 pm EDT | William H RastetterDirector | 16,000 | — | — | 16,000 | — | |
| May 2, 2018 AForm 4 → | May 4, 4:19 pm EDT | Amir NashatDirector | 16,000 | — | — | 16,000 | — | |
| May 2, 2018 AForm 4 → | May 4, 4:19 pm EDT | John MendleinDirector | 16,000 | — | — | 16,000 | — | |
| May 2, 2018 AForm 4 → | May 4, 4:17 pm EDT | Robert S EpsteinDirector | 16,000 | — | — | 16,000 | — | |
| May 2, 2018 AForm 4 → | May 4, 4:16 pm EDT | Timothy P CoughlinDirector | 16,000 | — | — | 16,000 | — | |
| Jan 16, 2018 AForm 4 → | Jan 17, 4:08 pm EST | J Scott WolchkoPresident and CEO, Director | 348,000 | — | — | 348,000 | — | |
| Jan 16, 2018 AForm 4 → | Jan 17, 4:06 pm EST | Cindy TahlGeneral Counsel and Secretary | 200,160 | — | — | 200,160 | — | |
| Jan 16, 2018 AForm 4 → | Jan 17, 4:06 pm EST | Chris StorgardChief Medical Officer | 186,000 | — | — | 186,000 | — | |
| Jan 16, 2018 AForm 4 → | Jan 17, 4:05 pm EST | Daniel D ShoemakerChief Scientific Officer | 186,000 | — | — | 186,000 | — | |
| Jan 16, 2018 AForm 4 → | Jan 17, 4:05 pm EST | Stewart AbbotChief Development Officer | 186,000 | — | — | 186,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 12:05 pm EDT | William H RastetterDirector | 25,000 | — | — | 25,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 12:03 pm EDT | Amir NashatDirector | 25,000 | — | — | 25,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 12:02 pm EDT | John MendleinDirector | 25,000 | — | — | 25,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 12:00 pm EDT | Robert S EpsteinDirector | 25,000 | — | — | 25,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 11:58 am EDT | Mark J EnyedyDirector | 25,000 | — | — | 25,000 | — | |
| May 2, 2017 AForm 4 → | May 4, 11:56 am EDT | Timothy P CoughlinDirector | 25,000 | — | — | 25,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 4:03 pm EST | J Scott WolchkoPresident and CEO, Director | 250,000 | — | — | 250,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 4:03 pm EST | Cindy TahlGeneral Counsel and Secretary | 150,000 | — | — | 150,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 4:03 pm EST | Chris StorgardChief Medical Officer | 150,000 | — | — | 150,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 4:02 pm EST | Daniel D ShoemakerChief Scientific Officer | 150,000 | — | — | 150,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 4:02 pm EST | Stewart AbbotChief Development Officer | 150,000 | — | — | 150,000 | — | |
| Aug 23, 2016 MForm 4 → | Aug 24, 6:55 pm EDT | J Scott WolchkoPresident and CEO, Director | 2,570 | — | — | 0 | — | |
| May 16, 2016 AForm 4 → | May 18, 12:19 pm EDT | Chris StorgardChief Medical Officer | 200,000 | — | — | 200,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 2:40 pm EDT | Mark J EnyedyDirector | 25,000 | — | — | 25,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 1:04 pm EDT | John MendleinDirector | 25,000 | — | — | 25,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 12:38 pm EDT | William H RastetterDirector | 25,000 | — | — | 25,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 12:35 pm EDT | Amir NashatDirector | 25,000 | — | — | 25,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 12:29 pm EDT | Robert S EpsteinDirector | 25,000 | — | — | 25,000 | — | |
| May 11, 2016 AForm 4 → | May 13, 12:24 pm EDT | Timothy P CoughlinDirector | 25,000 | — | — | 25,000 | — | |
| Jan 18, 2016 MForm 4 → | Jan 20, 2:32 pm EST | J Scott WolchkoPresident and CEO, Director | 7,500 | — | — | 27,935 | — | |
| Jan 12, 2016 AForm 4 → | Jan 14, 4:35 pm EST | J Scott WolchkoPresident and CEO, Director | 300,000 | — | — | 110,400 | — | |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:33 pm EST | Cindy TahlGeneral Counsel and Secretary | 135,600 | — | — | 135,600 | — | |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:32 pm EST | Daniel D ShoemakerChief Scientific Officer | 148,800 | — | — | 148,800 | — | |
| Jan 8, 2016 AForm 4 → | Jan 12, 5:30 pm EST | Stewart AbbotChief Development Officer | 148,800 | — | — | 148,800 | — | |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:33 pm EDT | Stewart AbbotChief Development Officer | 70,000 | — | — | 70,000 | — | |
| Oct 15, 2015 AForm 4 → | Oct 16, 5:32 pm EDT | Cindy TahlGeneral Counsel and Secretary | 50,000 | — | — | 50,000 | — | |
| May 13, 2015 AForm 4/A → | May 18, 1:37 pm EDT | Amir NashatDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| May 13, 2015 AForm 4 → | May 15, 6:12 pm EDT | Robert S EpsteinDirector | 10,000 | — | — | 10,000 | — | |
| May 13, 2015 AForm 4 → | May 15, 6:01 pm EDT | John MendleinDirector | 10,000 | — | — | 10,000 | — | |
| May 13, 2015 AForm 4 → | May 15, 5:51 pm EDT | William H RastetterDirector | 10,000 | — | — | 10,000 | — | |
| May 13, 2015 AForm 4 → | May 15, 5:13 pm EDT | Amir NashatDirector, 10% Owner | 10,000 | — | — | 10,000 | — | amended |
| May 13, 2015 AForm 4 → | May 15, 4:58 pm EDT | Mark J EnyedyDirector | 10,000 | — | — | 10,000 | — | |
| May 13, 2015 AForm 4 → | May 15, 4:49 pm EDT | Timothy P CoughlinDirector | 10,000 | — | — | 10,000 | — | |
| Apr 13, 2015 MForm 4 → | Apr 14, 4:22 pm EDT | J Scott WolchkoSee Remarks | 8,000 | — | — | 31,637 | — | |
| Apr 13, 2015 MForm 4 → | Apr 14, 3:52 pm EDT | Christian WeyerSee Remarks, Director | 25,000 | — | — | 258,040 | — | |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:42 pm EST | Peter D FlynnSee remarks | 70,000 | — | — | 70,000 | — | |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:35 pm EST | Daniel D ShoemakerChief Research Officer | 70,000 | — | — | 70,000 | — | |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:30 pm EST | Pratik S MultaniChief Medical Officer | 70,000 | — | — | 70,000 | — | |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:22 pm EST | J Scott WolchkoSee remarks | 70,000 | — | — | 70,000 | — | |
| Jan 5, 2015 AForm 4 → | Jan 7, 5:15 pm EST | Christian WeyerSee remarks, Director | 100,000 | — | — | 100,000 | — |